Cantourage Group SE | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
Cantourage Group SE

BRIEF

published on 11/20/2024 at 08:05, 1 day 2 hours ago

Cantourage Group SE Achieves EUR 5.5 Million Revenue in October 2024

Revenue Growth European Market Financial Targets Medical Cannabis Cantourage Group
PRESS RELEASE

published on 11/20/2024 at 08:00, 1 day 2 hours ago

New Sales Record: Cantourage Group SE Reports EUR 5.5 Million in Revenue for October 2024, Reaffirming Full-Year Growth Targets
Cantourage Group SE achieves new sales record of EUR 5.5 million in October 2024, confirming full-year growth targets. Continues as a leader in European cannabis market

Cantourage Group SE Growth Targets European Cannabis Market Sales Record EUR 5.5 Million
BRIEF

published on 11/07/2024 at 08:05, 14 days 2 hours ago

Cantourage Group SE Reports Strong Third Quarter EBITDA Growth

Sales Increase Cannabis Market Cantourage Group SE European Expansion EBITDA Growth
PRESS RELEASE

published on 11/07/2024 at 08:00, 14 days 2 hours ago

Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth
Cantourage Group SE achieves strong EBITDA growth of EUR 1.4 million in Q3 2024, with sales reaching EUR 30.2 million, continuing positive trend

Sales Profitable Growth Cannabis Market Cantourage Group SE EBITDA Growth
BRIEF

published on 10/10/2024 at 09:07, 1 month 11 days ago

Cantourage Group SE: Promising Growth Amid Cannabis Legalization

Profitability Sales Growth Telemedicine Medical Cannabis Cantourage
PRESS RELEASE

published on 10/10/2024 at 09:02, 1 month 11 days ago

Original-Research: Cantourage Group SE (von NuWays AG): Buy
Cantourage Group SE shows strong growth, aiming for EBITDA profitability. Sales up by 124% yoy in Q3, reaching €13.2m. FY24 guidance raised to at least €40m. Partnership with Portocanna expands processing capacity

Sales Partnership Growth Cantourage Group SE EBITDA Profitability
BRIEF

published on 10/10/2024 at 08:05, 1 month 11 days ago

Cantourage Group SE Reports Record Third Quarter Amid Medical Cannabis Boom

Record Revenue Medical Cannabis Cantourage Group SE 2024 Financial Forecast Germany Market Growth
PRESS RELEASE

published on 10/10/2024 at 08:00, 1 month 11 days ago

The medical cannabis market is booming: Cantourage Group SE reports record quarter in third quarter of 2024
Cantourage Group SE reports record sales quarter in Q3 2024, with revenue soaring to EUR 13.2 million and EBITDA of EUR 0.9-1.1 million. Strong growth expected for full year 2024

EBITDA Revenue Growth Medical Cannabis Cantourage Group SE Record Quarter
BRIEF

published on 09/05/2024 at 09:07, 2 months 16 days ago

Cantourage Group SE: FY24 Guidance Promises Robust Growth

Sales Growth Medical Cannabis Cantourage Group SE FY24 Guidance Germany Legalization
PRESS RELEASE

published on 09/05/2024 at 09:02, 2 months 16 days ago

Original-Research: Cantourage Group SE (von NuWays AG): Buy
Cantourage Group SE issues positive FY24 sales growth guidance following partial legalization of medical cannabis, expecting €37-43m sales. Anticipates strong growth in the UK market as well

Medical Cannabis Cantourage Group SE Germany Legalization FY24 Sales Growth UK Market Growth

1 2 ... 5

Accesswire

Published on 11/21/2024 at 10:03, 35 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 38 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 38 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 3 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 13 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 33 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 36 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 38 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 38 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 37 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 40 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 18 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 53 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 53 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE